Cavan Ventures Inc. (TSXV:CVN) announced that, in the interest of furthering its diversification into the medical marijuana and hemp industries, it has appointed Matthew Harvey to Cavan’s advisory board. As the CEO of BC Bud Depot, Mr. Harvey will aid Cavan in accelerating their growth in this burgeoning industry.

As quoted in the press release:


Mr. Harvey has been a master grower and in the industry since the mid 1990’s with world-wide exposure since 2004. Mr. Harvey is the Founder and CEO of BC Bud Depot (“BCBD”), a producer of marijuana seeds. BCBD takes pride in developing its award-winning THC and CBD cannabis strains. BCBD also collaborates with other breeders and dispensaries (including Reeferman Seeds, T.H.Seeds and DNA Genetics, and to European breeders like Soma Seeds and Delta-9 labs, and California’s The Honey Spot), and offers over 50 proprietary medicinal strains to date with access to over 150 marijuana strains collaborated together with associated partners. During Mr. Harvey’s tenure, BCBD has received over 21 Cannabis Cup awards, including 7 first place awards, 9 Top Strain awards, 6 top 3 strain awards and an induction in 2009 to the Seed Bank Hall of Fame award. Additionally, BC Bud Depot has outreach to over 11 North American dispensaries and over 60 worldwide retail and web stores which stock BCBD’S products. Most recently, Mr. Harvey has steered BCBD towards a new developmental approach to medicinal genetics, producing unique strains to be used for specific medical ailments.

Cavan CEO, Peter P. Swistak, said:

The depth and scope of Mr. Harvey’s knowledge is unparalleled and Cavan is very fortunate to have access to this knowledge as we believe he is the best in his field with an extensive bio and proven track record. He will add tremendous value, credibility and unique knowledge to Cavan in its analysis of the Medical Marijuana and Hemp/Cannabinoid industry, and potential opportunities in that industry. We are excited to have Mr. Harvey available to us while we conduct due-diligence in the Cannabinoid/Medicinal Marijuana space.

Click here to read the Cavan Ventures Inc. (TSXV:CVN) press release

See this press release on Marketwire

Achievements with Scalability and Compatibility Pave Way for Next Phase of Advancement

Codebase Ventures Inc. (“Codebase” or the “Company”) (CSE:CODE)(FSE:C5B)(OTCQB:BKLLF) is excited to announce that the Company’s holding, Arcology, a cluster-computing powered AI blockchain ecosystem with unlimited scalability, has updated its working roadmap in response to its Testnet 1.0 results

Keep reading... Show less

For the purposes of the Financial Conduct Authority’s Disclosure Guidance and Transparency Rules, World High Life announces that the Company has 230,119,819 ordinary shares of 1p each in issue (“Ordinary Shares”), each share carrying the right to one vote. The figure of 230,119,819 should be used by shareholders in the Company as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company under the Financial Conduct Authority’s Disclosure Guidance and Transparency Rules

The Directors of the Company accept responsibility for the contents of this announcement.

Keep reading... Show less

TransCanna Holdings Inc. (CSE: TCAN) (FSE: TH8) (“TransCanna” or the “Company”) announces that it has granted an aggregate of 400,000 options at an exercise price of CDN$1.00, exercisable for a period of five years, to directors and officers of the Company. The stock options are being granted pursuant to the terms of the Company’s stock option plan, and are subject to regulatory approval.

About TransCanna Holdings Inc.

Keep reading... Show less

Donation will benefit veteran-focused organizations and nonprofits, including all TruVet Program partners

Trulieve Cannabis Corp. (CSE: TRUL) (OTCQX: TCNNF) (“Trulieve” or “the Company”), a United States -based leading medical cannabis company, announced today a donation for all TruVet Program partners year-to-date in honor of Veterans Day. A total of $15,000 representing a portion of the November proceeds from the Company’s limited-edition Freedom Pre-Roll product, will be shared among program partners, which are veteran-focused organizations andor nonprofits.

Keep reading... Show less

Bronstein, Gewirtz & Grossman, LLC notifies investors that a class action lawsuit has been filed against Aurora Cannibas, Inc. (“Aurora” or the “Company”) (NYSE:ACB) and certain of its officers, on behalf of shareholders who purchased or otherwise acquired Aurora securities between February 13, 2020, and September 4, 2020, inclusive (the “Class Period”). Such investors are encouraged to join this case by visiting the firm’s site: www.bgandg.comacb

This class action seeks to recover damages against Defendants for alleged violations of the federal securities laws under the Securities Exchange Act of 1934.

Keep reading... Show less